Evolution of Gram-negative bacilli susceptibility in peritoneal dialysis-related peritonitis in Brazil: A single center's experience over nine years

Peritoneal Dialysis International

Volumn 29, Issue 2, 2009, Pages 230-233

  Barretti, Pasqual ^a   Pereira, Daniel ^a   Brasil, Maria Aparecida ^a   de Lourdes Cunha, Maria ^a   Caramori, Jacqueline ^a   Montelli, Augusto ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; OFLOXACIN;

ABDOMINAL PAIN; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; BRAZIL; CONTROLLED STUDY; ENTEROBACTER; ENTEROBACTERIACEAE; EPSILOMETER TEST; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SERRATIA MARCESCENS; ANTIBIOTIC RESISTANCE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; GRAM NEGATIVE INFECTION; MICROBIOLOGY; PERITONITIS;

BRAZIL; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONITIS; RETROSPECTIVE STUDIES;

EID: 67149107159     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900219     Document Type: Article

References (10)

1. Piraino B, Bernardini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal. dialysis patients. Perit Dial Int 2003; 23: 456-9.
2. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim,HJ, Choi KH, et al. Changes in causative organisms and their antimicrobial. susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004; 24: 424-32.
3. Prasad N, Gupta A, Sharma RK, Prasad KN, Gulati S, Sharma AP. The spectrum of bacterial peritonitis in CAPD patients in a developing country: is it different? Perit Dial Int 2003; 23:400-2.
4. Barretti P, Bastos KA, Dominguez J, Caramori JC. Peritonitis in Latin America. Perit Dial Int 2007; 27:332-9.
5. Szeto CC, Chow KM, Leung CB, Wong TY, Wu AK, Wang AY, et al. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases. Kidney Int 2001; 59:2309-15.
6. Pérez Fontan M, Rodríguez-Carmona A, Garda-Naveiro R, Rosales M, Villaverde P, Vatdés F. Peritonitis-reLated mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25:274-84.
7. Szeto CC, Chow VC, Chow KM, Lai RW, Chung KY, Leung CB, et al. Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int 2006; 69:1245-52.
8. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25:107-31.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S15. Wayne, PA. Clinical and Laboratory Standards Institute; 2005.
10. Baker RJ, Senior H, Clemenger M, Brown EA. Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 2003; 41:670-5.